Summary: • Many Liberians are misusing antibiotics, antiparasitic, antifungal and antiviral drugs without prescriptions, ...

Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as ...

The 30-day risk of a hospital visit for acute respiratory failure was higher among healthy adolescents and young adults ...

Enanta Pharmaceuticals, Inc.'s strong pipeline, positive RSV drug data, and solid cash position drive growth. Click for my ...

Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...

(Reuters) -Indian drugmaker Lupin posted a 73.3% jump in second-quarter profit on Thursday, driven by strong demand for its respiratory drugs. The firm, which produces complex biosimilars drugs and ...

Investing.com - Connect Biopharma Holdings Ltd (NASDAQ:CNTB) received a Buy rating initiation from BTIG on Friday, with a price target of $10.00. The $86.37 million market cap biotech is currently ...

GSK’s respiratory drug lineup spans a newly approved product for chronic obstructive pulmonary disease as well as therapeutic candidates in various stages of clinical development for treating this ...

Erratum: Impact of Lean Body Mass–Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial On June 6, 2024, ...

Indian pharma juggernaut Lupin—best known in the U.S. for its portfolio of generic drugs—is laying down new manufacturing roots in Florida. Lupin expects to invest a combined $250 million—covering R&D ...